---
document_datetime: 2023-09-21 21:36:49
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/xofluza-epar-all-authorised-presentations_en.pdf
document_name: xofluza-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9538412
conversion_datetime: 2025-12-24 23:06:51.883649
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form          | Route of Administration   | Immediate Packaging       | Content (concentration)   | Pack size                                                                                       |
|------------------|-------------------|------------|------------------------------|---------------------------|---------------------------|---------------------------|-------------------------------------------------------------------------------------------------|
| EU/1/20/1500/001 | Xofluza           | 20 mg      | Film-coated tablet           | Oral use                  | blister (OPA/alu/PVC/alu) |                           | 2 tablets                                                                                       |
| EU/1/20/1500/002 | Xofluza           | 40 mg      | Film-coated tablet           | Oral use                  | blister (OPA/alu/PVC/alu) |                           | 2 tablets                                                                                       |
| EU/1/20/1500/003 | Xofluza           | 80 mg      | Film-coated tablet           | Oral use                  | blister (OPA/alu/PVC/alu) |                           | 1 tablet                                                                                        |
| EU/1/20/1500/004 | Xofluza           | 40 mg      | Film-coated tablet           | Oral use                  | blister (OPA/alu/PVC/alu) |                           | 1 tablet                                                                                        |
| EU/1/20/1500/005 | Xofluza           | 2 mg/ml    | Granules for oral suspension | Oral use                  | Bottle (glass)            | 40 mg                     | 1 bottle +1 measuring cup + 1 bottle adapter + 1 oral syringe of 3 ml + 1 oral syringe of 10 ml |